Table 1. Guidelines with the recommendations for dual antiplatelet therapy.
| Indication for DAPT | Recommended duration of DAPT | Guideline (reference #) |
|---|---|---|
| Minor non-cardioembolic ischemic stroke (NIHSS score≤3) who did not receive IV alteplase | ASA + clopidogrel; 21 days | 2,3 |
| Acute coronary syndrome | DAPT; 3-36 months, in general 12 months | 4 |
| PCI in stable CAD setting | DAPT; 1-12 months | 4 |
| TAVI without high bleeding risk | ASA + clopidogrel; 3-6 months | 5 |
| Below the knee bypass with a prosthetic graft | ASA + clopidogrel; at least 1 year | 6,7 |
| Carotid artery stenting | ASA + clopidogrel; at least 1 month | 8 |
| Revascularization percutaneous in patients with lower extremity artery disease or infra-inguinal stent implementation | ASA + clopidogrel; at least 1 month | 6,7,9 |
DAPT: dual antiplatelet therapy; NIHSS: National Institutes of Health Stroke Scale; PCI: Percutaneous Coronary Intervention; CAD: Coronary artery disease; TAVI: Transcatheter aortic valve implantation; ASA: acetylsalicylic acid